Mechanism of DNA-dependent protein kinase inhibition by cis- diamminedichloroplatinum(II)-damaged DNA

John Turchi, Steve M. Patrick, Karen M. Henkels

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

We have determined the mechanism of DNA-dependent protein kinase (DNA-PK) inhibition by cis-diamminedichloroplatinum(II)- (cisplatin-) damaged DNA. We previously have demonstrated that Ku, the DNA binding subunit of DNA-PK, is capable of binding to DNA duplexes globally damaged with cisplatin but was unable to stimulate DNA-PK(cs), the catalytic subunit [Turchi and Henkels (1996) J. Biol. Chem. 271, 2992-3000]. In this report we have assessed Ku binding and DNA-PK stimulation using a series of DNA substrates containing single, site-specific d(GpG), d(ApG), and d(GpXpG) intrastrand cisplatin adducts and a substrate with a single interstrand cisplatin adduct. Results demonstrate that Ku binding is marginally decreased by the presence of cisplatin adducts on each substrate. When assayed for the ability to stimulate DNA-PK, each cisplatin-damaged substrate resulted in significantly decreased activity compared to undamaged DNA controls. The degree of inhibition of both Ku binding and kinase activity varied depending on the specific adduct employed. The inhibition of DNA-PK activity by cisplatin-damaged DNA was observed using either a synthetic peptide or human replication protein A as a substrate. Autophosphorylation of the DNA-PK(cs) and Ku subunits was also inhibited in reactions performed with cisplatin-damaged DNA, demonstrating that increased autophosphorylation of DNA- PK(cs) does not account for the decreased kinase activity observed with cisplatin-damaged DNA. Equilibrium binding and initial velocity experiments revealed a less than 2-fold increase in the K(d) of Ku and the K(m) of DNA-PK for DNA containing a single 1,2- d(GpG) cisplatin adduct. The mechanism of DNA-PK inhibition by cisplatin-damaged DNA can be attributed to a large decrease in the V(max) and small increase in K(m).

Original languageEnglish (US)
Pages (from-to)7586-7593
Number of pages8
JournalBiochemistry
Volume36
Issue number24
DOIs
StatePublished - Jun 17 1997
Externally publishedYes

Fingerprint

DNA-Activated Protein Kinase
Cisplatin
DNA
Substrates
Phosphotransferases

ASJC Scopus subject areas

  • Biochemistry

Cite this

Mechanism of DNA-dependent protein kinase inhibition by cis- diamminedichloroplatinum(II)-damaged DNA. / Turchi, John; Patrick, Steve M.; Henkels, Karen M.

In: Biochemistry, Vol. 36, No. 24, 17.06.1997, p. 7586-7593.

Research output: Contribution to journalArticle

Turchi, John ; Patrick, Steve M. ; Henkels, Karen M. / Mechanism of DNA-dependent protein kinase inhibition by cis- diamminedichloroplatinum(II)-damaged DNA. In: Biochemistry. 1997 ; Vol. 36, No. 24. pp. 7586-7593.
@article{275303e852084a7b84c973b1a4b58167,
title = "Mechanism of DNA-dependent protein kinase inhibition by cis- diamminedichloroplatinum(II)-damaged DNA",
abstract = "We have determined the mechanism of DNA-dependent protein kinase (DNA-PK) inhibition by cis-diamminedichloroplatinum(II)- (cisplatin-) damaged DNA. We previously have demonstrated that Ku, the DNA binding subunit of DNA-PK, is capable of binding to DNA duplexes globally damaged with cisplatin but was unable to stimulate DNA-PK(cs), the catalytic subunit [Turchi and Henkels (1996) J. Biol. Chem. 271, 2992-3000]. In this report we have assessed Ku binding and DNA-PK stimulation using a series of DNA substrates containing single, site-specific d(GpG), d(ApG), and d(GpXpG) intrastrand cisplatin adducts and a substrate with a single interstrand cisplatin adduct. Results demonstrate that Ku binding is marginally decreased by the presence of cisplatin adducts on each substrate. When assayed for the ability to stimulate DNA-PK, each cisplatin-damaged substrate resulted in significantly decreased activity compared to undamaged DNA controls. The degree of inhibition of both Ku binding and kinase activity varied depending on the specific adduct employed. The inhibition of DNA-PK activity by cisplatin-damaged DNA was observed using either a synthetic peptide or human replication protein A as a substrate. Autophosphorylation of the DNA-PK(cs) and Ku subunits was also inhibited in reactions performed with cisplatin-damaged DNA, demonstrating that increased autophosphorylation of DNA- PK(cs) does not account for the decreased kinase activity observed with cisplatin-damaged DNA. Equilibrium binding and initial velocity experiments revealed a less than 2-fold increase in the K(d) of Ku and the K(m) of DNA-PK for DNA containing a single 1,2- d(GpG) cisplatin adduct. The mechanism of DNA-PK inhibition by cisplatin-damaged DNA can be attributed to a large decrease in the V(max) and small increase in K(m).",
author = "John Turchi and Patrick, {Steve M.} and Henkels, {Karen M.}",
year = "1997",
month = "6",
day = "17",
doi = "10.1021/bi963124q",
language = "English (US)",
volume = "36",
pages = "7586--7593",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "24",

}

TY - JOUR

T1 - Mechanism of DNA-dependent protein kinase inhibition by cis- diamminedichloroplatinum(II)-damaged DNA

AU - Turchi, John

AU - Patrick, Steve M.

AU - Henkels, Karen M.

PY - 1997/6/17

Y1 - 1997/6/17

N2 - We have determined the mechanism of DNA-dependent protein kinase (DNA-PK) inhibition by cis-diamminedichloroplatinum(II)- (cisplatin-) damaged DNA. We previously have demonstrated that Ku, the DNA binding subunit of DNA-PK, is capable of binding to DNA duplexes globally damaged with cisplatin but was unable to stimulate DNA-PK(cs), the catalytic subunit [Turchi and Henkels (1996) J. Biol. Chem. 271, 2992-3000]. In this report we have assessed Ku binding and DNA-PK stimulation using a series of DNA substrates containing single, site-specific d(GpG), d(ApG), and d(GpXpG) intrastrand cisplatin adducts and a substrate with a single interstrand cisplatin adduct. Results demonstrate that Ku binding is marginally decreased by the presence of cisplatin adducts on each substrate. When assayed for the ability to stimulate DNA-PK, each cisplatin-damaged substrate resulted in significantly decreased activity compared to undamaged DNA controls. The degree of inhibition of both Ku binding and kinase activity varied depending on the specific adduct employed. The inhibition of DNA-PK activity by cisplatin-damaged DNA was observed using either a synthetic peptide or human replication protein A as a substrate. Autophosphorylation of the DNA-PK(cs) and Ku subunits was also inhibited in reactions performed with cisplatin-damaged DNA, demonstrating that increased autophosphorylation of DNA- PK(cs) does not account for the decreased kinase activity observed with cisplatin-damaged DNA. Equilibrium binding and initial velocity experiments revealed a less than 2-fold increase in the K(d) of Ku and the K(m) of DNA-PK for DNA containing a single 1,2- d(GpG) cisplatin adduct. The mechanism of DNA-PK inhibition by cisplatin-damaged DNA can be attributed to a large decrease in the V(max) and small increase in K(m).

AB - We have determined the mechanism of DNA-dependent protein kinase (DNA-PK) inhibition by cis-diamminedichloroplatinum(II)- (cisplatin-) damaged DNA. We previously have demonstrated that Ku, the DNA binding subunit of DNA-PK, is capable of binding to DNA duplexes globally damaged with cisplatin but was unable to stimulate DNA-PK(cs), the catalytic subunit [Turchi and Henkels (1996) J. Biol. Chem. 271, 2992-3000]. In this report we have assessed Ku binding and DNA-PK stimulation using a series of DNA substrates containing single, site-specific d(GpG), d(ApG), and d(GpXpG) intrastrand cisplatin adducts and a substrate with a single interstrand cisplatin adduct. Results demonstrate that Ku binding is marginally decreased by the presence of cisplatin adducts on each substrate. When assayed for the ability to stimulate DNA-PK, each cisplatin-damaged substrate resulted in significantly decreased activity compared to undamaged DNA controls. The degree of inhibition of both Ku binding and kinase activity varied depending on the specific adduct employed. The inhibition of DNA-PK activity by cisplatin-damaged DNA was observed using either a synthetic peptide or human replication protein A as a substrate. Autophosphorylation of the DNA-PK(cs) and Ku subunits was also inhibited in reactions performed with cisplatin-damaged DNA, demonstrating that increased autophosphorylation of DNA- PK(cs) does not account for the decreased kinase activity observed with cisplatin-damaged DNA. Equilibrium binding and initial velocity experiments revealed a less than 2-fold increase in the K(d) of Ku and the K(m) of DNA-PK for DNA containing a single 1,2- d(GpG) cisplatin adduct. The mechanism of DNA-PK inhibition by cisplatin-damaged DNA can be attributed to a large decrease in the V(max) and small increase in K(m).

UR - http://www.scopus.com/inward/record.url?scp=0031003383&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031003383&partnerID=8YFLogxK

U2 - 10.1021/bi963124q

DO - 10.1021/bi963124q

M3 - Article

C2 - 9200710

AN - SCOPUS:0031003383

VL - 36

SP - 7586

EP - 7593

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 24

ER -